In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 839-845

  Zurenko, Gary E ^a   Yagi, Betty H ^a   Schaadt, Ronda D ^a   Allison, John W ^a   Kilburn, James O ^b   Glickman, Suzanne E ^b   Hutchinson, Douglas K ^a   Barbachyn, Michael R ^a   Brickner, Steven J ^a  

^a PFIZER INC   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; EPEREZOLID; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LINEZOLID; METICILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CROSS RESISTANCE; DRUG RESISTANCE; ISOLATION PROCEDURE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; STRAIN DIFFERENCE;

EID: 0029942573     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.839     Document Type: Article

References (22)

1. Ashtekar, D. R., R. Costa-Periera, T. Shrinivasan, R. Iyyer, N. Vishvanathan, and W. Rittel. 1991. Oxazohdinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobactenum tuberculosis Diagn. Microbiol Infect. Dis. 14:456-471.
2. Barry, A. L. 1988. In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents Antimicrob. Agents Chemother 32:150-152.
3. Brickner, S- J., D. K. Hutchinson, M. R. Barbachyn, S. A. Garmon, K. C. Grega, S. K, Hendges, P. R. Manninen, D. S. Toops, D. A. Ulanowicz, J. O. Kilburn, S. Glickman, G. E. Zurenko, and C. W. Ford, 1995. Synthesis of U-100592 and U-100766, two new oxazolidmone antibacterial agents in clinical trials for treatment of multiply resistant gram positive infections, abstr. F208. p. 149. In Program and abstracts of the 35th Interscienee Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C
4. Brickner, S. J., P. R. Manninen, D. A. Ulanowicz, K. D. Lovasz, and D. C. Rohrer. 1993 Multicyclic fused-ring oxazolidinone antibacterial agents, abstr. 89. In Abstracts of papers of the 206th National Meeting of the American Chemical Society. American Chemical Society, Washington. D.C
5. Brumfitt, W., and J. M. T. Hamilton-Miller. 1988. In vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones J. Antimicrob. Chemcither. 21:711-720.
6. Burrows, M. 1994. Unpublished data.
7. Chiba, K. 1994. Unpublished data.
8. Craig, W, A., and B. Suh. 1991. Protein binding and antimicrobial effects: methods for the determination of protein binding, p. 367-402. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore
9. Daly, J. S., G. M. Eliopoulos, E. Reiszner, and R, C. Moellering, Jr. 1988. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds. J Antimicrob. Chemother. 21:721-730.
10. Daly, J. S., G. M. Eliopoulis, S. Willey, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound Antimicrob Agents Chemother 32:1341-1346.
11. Eustice. D. C., P. A. Feldman, and A. M. Slee. 1988. The mechanism of action of DuP 721, a new antibacterial agent, effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150:965-971.
12. Eustice, D. C., P. A. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32:1218-1222.
13. Ford, C. W., J. C. Hamel, J. K. Moerman, D. Stapert, D. M. Wilson, R. J. Yancey, M. R. Barbachyn, D. K. Hutchison, and S. J. Brickner. 1995. In vivo efficacy evaluations of U-100592 and U-100766, new oxazolidinone antibiotics, abstr. F221. p. 151. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C
14. Krogstad, O. J., and A. R. Parquette. 1980. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob. Agents Chemother 17:965-968.
15. Mini, E., A. Vovelli, T. Mazzei, and P. Periti. 1989. Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. Eur. J. Clin. Microbiol. Infect. Dis. 8:256-260.
16. National Committee for Clinical Laboratory Standards. 1993. Approved standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova. Pa.
17. National Committee for Clinical Laboratory Standards. 1993. Approved standard Methods for antimicrobial susceptibility testing of anaerobic bacteria, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Neu, H. C., A. Novelli, G. Saha, and N. Chin. 1988. In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105, Antimicrob. Agents Chemother 32:580-583.
19. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterials: in vitro and in vivo activities of DuP 105 and DuP 721, abstr 244, p. 139. In Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob. Agents Chemother 31:1791-1797.
21. Stratton, C. W., C. Liu, H. B. Ratner, and L. S. Weeks. 1987. Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by time-kill kinetic studies. Antimicrob. Agents Chemother. 31:1014-1016.
22. Zajac, I., G. N. Lam, H. E. Hoffman, and A. M. Slee. 1987. Pharmacokinctics of DuP 721, a new synthetic oxazolidinone antibacterial, abstr. 247, p. 140. In Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D C.